Creatine Kinase
CardiacWhat is Creatine Kinase?
Creatine kinase (CK), also known as creatine phosphokinase (CPK), is an enzyme that catalyzes the reversible transfer of a phosphate group from phosphocreatine to ADP, regenerating ATP—the cell's primary energy currency. This reaction is critical in tissues with high and fluctuating energy demands, particularly skeletal muscle, cardiac muscle, and the brain. CK exists in three isoenzyme forms: CK-MM (predominant in skeletal muscle, accounting for ~95% of total CK in serum), CK-MB (found mainly in cardiac muscle, typically 1–3% of total CK), and CK-BB (found in the brain and smooth muscle, rarely detected in serum).
Total CK is a well-established marker of muscle damage. When muscle cells are injured—whether from exercise, trauma, ischemia, or disease—CK leaks into the bloodstream in proportion to the degree of damage. While CK-MB was historically the primary cardiac biomarker for diagnosing myocardial infarction, high-sensitivity troponin assays have largely supplanted it for this purpose. Total CK remains essential for diagnosing rhabdomyolysis, monitoring myopathies and muscular dystrophies, and detecting statin-related muscle toxicity.
Why It Matters
CK is the most sensitive widely available marker for skeletal muscle injury. In rhabdomyolysis, CK levels can exceed 10,000–100,000 U/L or higher, and the degree of elevation correlates with the risk of acute kidney injury from myoglobin-induced tubular damage. CK monitoring is also critical for patients on statin therapy, as statins can rarely cause myopathy or rhabdomyolysis. In neuromuscular diseases such as Duchenne muscular dystrophy, CK levels are typically elevated 10–100 times normal even before clinical symptoms appear, making it useful for early detection and monitoring. CK-MB, while less used now, still plays a role in detecting reinfarction in patients who have already had a heart attack, as it rises and falls more quickly than troponin.
Normal Reference Ranges
| Group | Range | Unit |
|---|---|---|
| Adult Men | 39–308 | U/L |
| Adult Women | 26–192 | U/L |
| Children | 60–305 | U/L |
| Newborns | 68–580 | U/L |
Reference ranges may vary by laboratory. Always compare results to the ranges provided by your testing facility.
What High CK Levels Mean
Common Causes
- Rhabdomyolysis (crush injury, prolonged immobilization, hyperthermia)
- Intense or prolonged exercise (especially eccentric exercise)
- Myocardial infarction (CK-MB fraction elevated)
- Muscular dystrophies (Duchenne, Becker)
- Inflammatory myopathies (polymyositis, dermatomyositis)
- Hypothyroidism-associated myopathy
- Statin or other drug-induced myopathy
- Seizures (prolonged)
- Intramuscular injections
- Malignant hyperthermia
Possible Symptoms
- Muscle pain, tenderness, and swelling
- Muscle weakness
- Dark brown or tea-colored urine (myoglobinuria in rhabdomyolysis)
- Decreased urine output (if acute kidney injury develops)
- Chest pain with cardiac CK-MB elevation
- Fatigue and malaise
What to do: The clinical context dictates management. For suspected rhabdomyolysis (CK >5x normal with risk factors), aggressive intravenous fluid resuscitation is critical to prevent kidney damage. Monitor renal function, electrolytes (especially potassium and calcium), and urine output. For suspected cardiac causes, troponin is the preferred biomarker. If statin-related, hold the statin and recheck CK. For neuromuscular disease, refer for neurological evaluation and possible muscle biopsy or genetic testing.
What Low CK Levels Mean
Common Causes
- Low muscle mass (sarcopenia, cachexia, or prolonged immobility)
- Connective tissue diseases (rheumatoid arthritis, lupus—some patients)
- Alcoholic liver disease (reduced muscle mass)
- Early pregnancy
Possible Symptoms
- Low CK itself does not cause symptoms
- May reflect underlying muscle wasting or deconditioning
What to do: Low CK is usually not clinically concerning and often reflects low muscle mass. If accompanied by muscle weakness, consider a neurological evaluation. Ensure adequate nutrition and physical activity. No specific treatment is needed for isolated low CK.
When Is CK Testing Recommended?
- When rhabdomyolysis is suspected (dark urine, muscle pain after crush injury or extreme exertion)
- When monitoring patients on statin therapy who develop muscle symptoms
- In the evaluation of suspected myopathies or muscular dystrophies
- As part of the workup for suspected myocardial infarction (CK-MB, though troponin is preferred)
- When monitoring drug-related muscle toxicity (colchicine, daptomycin)
Frequently Asked Questions
Related Biomarkers
Want your CK levels analyzed?
Upload your lab results for an instant AI-powered breakdown of all your biomarkers.
Upload Lab Results →Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reference ranges may vary between laboratories. Always consult your healthcare provider for interpretation of your specific test results.